These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26512931)

  • 21. Protective effects of oxymatrine on experimental diabetic nephropathy.
    Guo C; Han F; Zhang C; Xiao W; Yang Z
    Planta Med; 2014 Mar; 80(4):269-76. PubMed ID: 24535719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling.
    Hsieh TJ; Chen R; Zhang SL; Liu F; Brezniceanu ML; Whiteside CI; Fantus IG; Ingelfinger JR; Hamet P; Chan JS
    Kidney Int; 2006 Mar; 69(6):1005-15. PubMed ID: 16528250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
    Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
    Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.
    Fujisawa G; Okada K; Muto S; Fujita N; Itabashi N; Kusano E; Ishibashi S
    Kidney Int; 2004 Oct; 66(4):1493-502. PubMed ID: 15458443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional Suppression of Diabetic Nephropathy with Novel Gene Silencer Pyrrole-Imidazole Polyamides Preventing USF1 Binding to the TGF-β1 Promoter.
    Okamura M; Fukuda N; Horikoshi S; Kobayashi H; Tsunemi A; Akiya Y; Endo M; Matsumoto T; Abe M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on protective effects and its mechanism of leflunomide on renal tissue in rat IgA nephropathy model].
    Tang Y; Lou TQ; Wang C; Peng H; Liu X; Tang H
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):283-5. PubMed ID: 18471359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
    Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
    Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.
    Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P
    J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat.
    Toba H; Sawai N; Morishita M; Murata S; Yoshida M; Nakashima K; Morita Y; Kobara M; Nakata T
    Eur J Pharmacol; 2009 Jun; 612(1-3):106-14. PubMed ID: 19356735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.
    Li L; Emmett N; Mann D; Zhao X
    Exp Biol Med (Maywood); 2010 Mar; 235(3):383-91. PubMed ID: 20404057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.
    Zhang W; Miao J; Ma C; Han D; Zhang Y
    Peptides; 2012 Aug; 36(2):186-91. PubMed ID: 22687367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-beta1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy].
    Liu S; Tang LQ; Chen LM; Chen XQ; Zhang ST; Wei Y
    Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):68-72. PubMed ID: 18338624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephro-protective effect of granulocyte colony-stimulating factor in streptozotocin induced diabetic rats.
    Erbas O; Yapislar H; Oltulu F; Yavasoğlu A; Aktug H; Taskiran D
    Biotech Histochem; 2014 Oct; 89(7):488-96. PubMed ID: 24707907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy.
    Elrashidy RA; Asker ME; Mohamed HE
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):324-33. PubMed ID: 22261714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
    Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
    Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ
    Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB; Zhang L; Yang LY
    Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.